Journal of Nuclear Cardiology

, Volume 14, Issue 6, pp 827–834 | Cite as

Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease

  • Eliana Reyes
  • Chee Y. Loong
  • Kshama Wechalekar
  • Katherine Latus
  • Constantinos Anagnostopoulos
  • S. Richard Underwood
Original Articles
Received:
Accepted:

Abstract

Background

Adenosine may cause bronchoconstriction in subjects with asthma or chronic obstructive pulmonary disease (COPD). Recent evidence suggests that this effect may be dependent on the severity of disease. This study investigates the tolerability of adenosine stress in patients with mild asthma or COPD undergoing myocardial perfusion scintigraphy.

Methods and Results

In this case-control study patients with known or suspected mild asthma or COPD were pretreated with an inhaled β2-adrenergic agonist and adenosine titrated up to the maximal dose of 140 μg·kg−1·min−1 over a period of 6 minutes. The occurrence of side effects and test tolerability were compared between the airway disease group and 72 control subjects. Of 1261 patients, 124 had known or suspected airway disease; of these, 72 (58%) were suitable for adenosine stress. The proportion of tests completed as per protocol in the asthma/COPD group was similar to that of control subjects (93% vs 100%, P=.06). Dyspnea (n=38 [53%] in asthma/COPD group vs n=25 [35%] in control group, P=.03) and chest pain (n=14 [19%] in asthma/COPD group vs n=16 [22%] in control group, P=.7) were the most common side effects, and these were mostly mild and well tolerated. Bronchospasm occurred in 5 patients with asthma/COPD but reverted shortly after discontinuation of the adenosine infusion. Aminophylline was not required in any case.

Conclusions

A stepwise 6-minute adenosine infusion with prophylactic β2-adrenergic agonist is safe and well tolerated in patients with mild asthma or COPD.

Key Words

Adenosine myocardial perfusion scintigraphy coronary artery disease obstructive airway disease 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Loong CY, Anagnostopoulos C. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging. Heart 2004;90(Suppl 5).v2–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Van Den BM, Polosa R, Kerstjens HA, Postma DS. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2004;114: 737–46.CrossRefGoogle Scholar
  3. 3.
    Basoglu OK, Pelleg A, Essilfie-Quaye S, Brindicci C, Barnes PJ, Kharitonov SA. Effects of aerosolized adenosine 5′-triphosphate vs adenosine 5′-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 2005;128: 1905–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Johnston DL, Scanlon PD, Hodge DO, Glynn RB, Hung JC, Gibbons RJ. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease. Mayo Clin Proc 1999;74:339–46.PubMedCrossRefGoogle Scholar
  5. 5.
    Balan KK, Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm? Am Heart J 2001;142:142–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Lenfant C NHLBI guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. NHI Publication No. 97-4051, 1997.Google Scholar
  7. 7.
    Celli BR, Snider GL, Heffner J, Tiep B, Ziment I, Make B, et al. Standards for the diagnosis and management of patients with COPD. American Thoracic Society. Am J Respir Crit Care Med 1995;152: 577–121.Google Scholar
  8. 8.
    Anagnostopoulos C, Harbinson M, Kelion A, Kundley K, Loong CY, Notghi A, et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 2004;90(Suppl 1):i1–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healtheare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Kiss D, Veegh W, Schragel D, Bachl C, Stollberger C, Sertl K. Bronchial asthma causing symptoms suggestive of angina pectoris. Eur Respir J 2003;21:473–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Hurart L, Ernst P, Suissa S. Cardiovascular morbidity and mortal ity in COPD. Chest 2005;128:2640–6.CrossRefGoogle Scholar
  12. 12.
    Varga A, Garcia MA, Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 2006;98:541–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JR Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000;36: 2017–27.PubMedCrossRefGoogle Scholar
  14. 14.
    Pennell DJ, Mavrogeni SI, Forbat SM, Karwatowski SP, Underwood SR. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995;25:1300–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 1983;15:161–5.PubMedGoogle Scholar
  16. 16.
    Henzlova M, Cerqueira MD, Mahmarian JJ, Yao SS. Stress protocols and tracers. J Nucl Cardiol 2006;13:e80–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Van Den BM, Meijer RJ, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, et al. PC(20) adenosme 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 2001, 163:1546–50.Google Scholar
  18. 18.
    Lee DK, Gray RD, Lipworth BJ. Adenosine monophosphate bronchial provocation and the actions of asthma therapy. Clin Exp Allergy 2003;33:287–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology XXV: nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527–52.PubMedGoogle Scholar
  21. 21.
    Zhong H, Shlykov SG, Molina JG, Sanborn BM, Jacobson MA, Tilley SL, et al. Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol 2003;171:338–45.PubMedGoogle Scholar
  22. 22.
    Larsson K, Sollevi A. Influence of infused adenosine on bronchial tone and bronchial reactivity in asthma. Chest 1988;93:280–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Phillips GD, Holgate ST. Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5′-monophosphate in atopic and non-atopic asthma. Clin Sci (Lond) 1988;75:429–36.Google Scholar
  24. 24.
    Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, Zeng D, A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 2004;30:118–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I. Adenosine-activated mast cell induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 2004;172:7726–33.PubMedGoogle Scholar
  26. 26.
    Gao Z, Li Z, Baker SP, Lasley RD, Meyer S, Elzein E, et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001;298:209–18.PubMedGoogle Scholar
  27. 27.
    Zhao G, Linke A, Xu X, Ochoa M, Belloni F, Belardinelli L, et al. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 2003;3:182–9.CrossRefGoogle Scholar
  28. 28.
    Hendel RC, Bateman TM, Cerqueira MD, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;46: 2069–75.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2007

Authors and Affiliations

  • Eliana Reyes
    • 1
    • 2
  • Chee Y. Loong
    • 1
    • 2
  • Kshama Wechalekar
    • 2
  • Katherine Latus
    • 2
  • Constantinos Anagnostopoulos
    • 2
  • S. Richard Underwood
    • 1
    • 2
  1. 1.National Heart and Lung InstituteImperial College LondonLondonEngland
  2. 2.Department of Nuclear MedicineRoyal Brompton HospitalLondonEngland

Personalised recommendations